Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Mutations conferring resistance to first-line anti-tuberculosis drugs in Peru: a systematic review of the literature].

Revista peruana de medicina experimental y salud publica - 1 Jan 2000

Vigo Aiko, Solari Lely, Santos David, Puyén Zully M

Abstract excerpt

OBJECTIVE.: To systematize available information regarding mutations that confer resistance to first-line anti-tuberculosis drugs. MATERIALS AND METHODS.: A systematic review of the scientific literature was conducted to identify articles that reported mutations conferring resistance to first-line anti-tuberculosis drugs. This search emphasized resistance to isoniazid and rifampicin drugs in M. tuberculosis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Drug Resistance, Bacterial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Molecular Diagnostic Techniques

Share to Mycobacterium tuberculosis

Share to Tuberculosis

Share to Tuberculosis, Multidrug-Resistant

Source

Identifiers

PMID: 31967255
DOI: 10.17843/rpmesp.2019.364.4722

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Mutations conferring resistance to first-line anti-tuberculosis drugs in Peru: a systematic review of the literature].PMID 31967255Read ↗

Utility of Phenotypic and Genotypic Testing in the Study of Mycobacterium tuberculosis Resistance to First-Line Anti-Tuberculosis drugs.Semantic proximity Read ↗

Mechanisms of drug resistance in Mycobacterium tuberculosis.Semantic proximity Read ↗

Molecular mechanisms of action, resistance, detection to the first-line anti tuberculosis drugs: Rifampicin and pyrazinamide in the post whole genome sequencing era.Semantic proximity Read ↗

Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.Semantic proximity Read ↗

Molecular characterisation of second-line drug resistance among drug resistant tuberculosis patients tested in Uganda: a two and a half-year's review.Semantic proximity Read ↗

[Molecular mechanisms of multidrug resistance in Mycobacterium tuberculosis].Semantic proximity Read ↗

Characterization of clinical isolates of Mycobacterium tuberculosis resistant to drugs and detection of RpoB mutation in multidrug-resistant tuberculosis in the Philippines.Semantic proximity Read ↗

Molecular determinants of drug resistance in tuberculosis.Semantic proximity Read ↗

[Phenotypic characterization of pyrazinamide-resistant Mycobacterium tuberculosis isolated in Poland].Semantic proximity Read ↗

Mycobacterium tuberculosis: drug-resistance mechanisms.Semantic proximity Read ↗

[Update on multidrug resistant tuberculosis in Switzerland].Semantic proximity Read ↗

Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.